Total Valuation
Elanco Animal Health has a market cap or net worth of $206.86B. The enterprise value is $15.84K.
Market Cap$206.86B
Enterprise Value$15.84K
Share Statistics
Elanco Animal Health has 499,621,830 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding499,621,830
Owned by Insiders1.00%
Owned by Institutions9.68%
Financial Efficiency
Elanco Animal Health’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 2.13%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)2.13%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee488.60K
Profits Per Employee-24.04K
Employee Count9,650
Asset Turnover0.35
Inventory Turnover1.53
Valuation Ratios
The current PE Ratio of Elanco Animal Health is ―. Elanco Animal Health’s PEG ratio is 0.28.
PE Ratio―
PS Ratio2.38
PB Ratio1.72
Price to Fair Value1.72
Price to FCF39.55
Price to Operating Cash Flow19.83
PEG Ratio0.28
Income Statement
In the last 12 months, Elanco Animal Health had revenue of 4.71B and earned -232.00M in profits. Earnings per share was -0.47.
Revenue4.71B
Gross Profit2.05B
Operating Income252.00M
Pretax Income-224.00M
Net Income-232.00M
EBITDA676.00M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was 617.00M and capital expenditures -238.00M, giving a free cash flow of 379.00M billion.
Operating Cash Flow617.00M
Free Cash Flow379.00M
Free Cash Flow per Share0.76
Dividends & Yields
Elanco Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.02
52-Week Price Change27.73%
50-Day Moving Average380.00
200-Day Moving Average379.07
Relative Strength Index (RSI)2.55
Average Volume (3m)0.00
Important Dates
Elanco Animal Health upcoming earnings date is Nov 10, 2026, Before Open (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
Elanco Animal Health as a current ratio of 2.17, with Debt / Equity ratio of 59.47%
Current Ratio2.17
Quick Ratio1.08
Debt to Market Cap0.36
Net Debt to EBITDA5.14
Interest Coverage Ratio1.15
Taxes
In the past 12 months, Elanco Animal Health has paid 8.00M in taxes.
Income Tax8.00M
Effective Tax Rate-0.04
Enterprise Valuation
Elanco Animal Health EV to EBITDA ratio is 21.75, with an EV/FCF ratio of 51.78.
EV to Sales3.12
EV to EBITDA21.75
EV to Free Cash Flow51.78
EV to Operating Cash Flow26.26
Balance Sheet
Elanco Animal Health has $530.00M in cash and marketable securities with $3.92B in debt, giving a net cash position of -$3.39B billion.
Cash & Marketable Securities$530.00M
Total Debt$3.92B
Net Cash-$3.39B
Net Cash Per Share-$6.78
Tangible Book Value Per Share-$3.30
Margins
Gross margin is 52.59%, with operating margin of 5.34%, and net profit margin of -4.92%.
Gross Margin52.59%
Operating Margin5.34%
Pretax Margin-4.75%
Net Profit Margin-4.92%
EBITDA Margin14.34%
EBIT Margin-0.08%
Analyst Forecast
The average price target for Elanco Animal Health is $529.52, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$529.52
Price Target Upside39.35% Upside
Analyst ConsensusStrong Buy
Analyst Count12
Revenue Growth Forecast1.60%
EPS Growth Forecast-144.91%